🚀 VC round data is live in beta, check it out!
Corpovael Valuation Multiples
Discover revenue and EBITDA valuation multiples for Corpovael and similar public comparables like Abitare In, Athos Immobilien, Mitre Realty, Libertas and more.
Corpovael Overview
About Corpovael
Corpovael SA de CV is engaged in developing, building and commercializing accessible housing for the middle and lower level of the Mexicans. The company seeks new investment alternatives in other States of the Republic in order to provide a home for more Mexicans.
Founded
2007
HQ
Employees
N/A
Website
Sectors
Financials (LTM)
EV
$178M
Corpovael Financials
Corpovael reported last 12-month revenue of $297M and EBITDA of $46M.
In the same LTM period, Corpovael generated $70M in gross profit, $46M in EBITDA, and $23M in net income.
Revenue (LTM)
Corpovael P&L
In the most recent fiscal year, Corpovael reported revenue of $295M and EBITDA of $46M.
Corpovael expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $297M | XXX | $295M | XXX | XXX | XXX |
| Gross Profit | $70M | XXX | $67M | XXX | XXX | XXX |
| Gross Margin | 24% | XXX | 23% | XXX | XXX | XXX |
| EBITDA | $46M | XXX | $46M | XXX | XXX | XXX |
| EBITDA Margin | 15% | XXX | 15% | XXX | XXX | XXX |
| EBIT Margin | 9% | XXX | 9% | XXX | XXX | XXX |
| Net Profit | $23M | XXX | $24M | XXX | XXX | XXX |
| Net Margin | 8% | XXX | 8% | XXX | XXX | XXX |
| Net Debt | — | — | $69M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Corpovael Stock Performance
Corpovael has current market cap of $85M, and enterprise value of $178M.
Market Cap Evolution
Corpovael's stock price is $0.29.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $178M | $85M | 0.0% | XXX | XXX | XXX | $0.08 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCorpovael Valuation Multiples
Corpovael trades at 0.6x EV/Revenue multiple, and 3.9x EV/EBITDA.
EV / Revenue (LTM)
Corpovael Financial Valuation Multiples
As of April 7, 2026, Corpovael has market cap of $85M and EV of $178M.
Equity research analysts estimate Corpovael's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Corpovael has a P/E ratio of 3.7x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $85M | XXX | $85M | XXX | XXX | XXX |
| EV (current) | $178M | XXX | $178M | XXX | XXX | XXX |
| EV/Revenue | 0.6x | XXX | 0.6x | XXX | XXX | XXX |
| EV/EBITDA | 3.9x | XXX | 3.9x | XXX | XXX | XXX |
| EV/EBIT | 6.5x | XXX | 6.6x | XXX | XXX | XXX |
| EV/Gross Profit | 2.5x | XXX | 2.7x | XXX | XXX | XXX |
| P/E | 3.7x | XXX | 3.6x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 3.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Corpovael Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Corpovael Margins & Growth Rates
Corpovael's revenue in the last 12 month grew by 4%.
Corpovael's rule of 40 is 22% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Corpovael's rule of X is 31% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Corpovael Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | 2% | XXX | XXX | XXX |
| EBITDA Margin | 15% | XXX | 15% | XXX | XXX | XXX |
| EBITDA Growth | 4% | XXX | 3% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 22% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 31% | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 7% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 7% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 14% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Corpovael Public Comps
See public comps and valuation multiples for other Real Estate Development comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Abitare In | XXX | XXX | XXX | XXX | XXX | XXX |
| Athos Immobilien | XXX | XXX | XXX | XXX | XXX | XXX |
| Mitre Realty | XXX | XXX | XXX | XXX | XXX | XXX |
| Libertas | XXX | XXX | XXX | XXX | XXX | XXX |
| Inpro | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Corpovael M&A Activity
Corpovael acquired XXX companies to date.
Last acquisition by Corpovael was on XXXXXXXX, XXXXX. Corpovael acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Corpovael
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCorpovael Investment Activity
Corpovael invested in XXX companies to date.
Corpovael made its latest investment on XXXXXXXX, XXXXX. Corpovael invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Corpovael
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Corpovael
| When was Corpovael founded? | Corpovael was founded in 2007. |
| Where is Corpovael headquartered? | Corpovael is headquartered in Mexico. |
| Is Corpovael publicly listed? | Yes, Corpovael is a public company listed on Bolsa Mexicana de Valores. |
| What is the stock symbol of Corpovael? | Corpovael trades under CADUA ticker. |
| When did Corpovael go public? | Corpovael went public in 2015. |
| Who are competitors of Corpovael? | Corpovael main competitors are Abitare In, Athos Immobilien, Mitre Realty, Libertas. |
| What is the current market cap of Corpovael? | Corpovael's current market cap is $85M. |
| What is the current revenue of Corpovael? | Corpovael's last 12 months revenue is $297M. |
| What is the current revenue growth of Corpovael? | Corpovael revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of Corpovael? | Current revenue multiple of Corpovael is 0.6x. |
| Is Corpovael profitable? | Yes, Corpovael is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Corpovael? | Corpovael's last 12 months EBITDA is $46M. |
| What is Corpovael's EBITDA margin? | Corpovael's last 12 months EBITDA margin is 15%. |
| What is the current EV/EBITDA multiple of Corpovael? | Current EBITDA multiple of Corpovael is 3.9x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.